In-depth cytogenetic and immunohistochemical analysis in a real world cohort - reconsidering the role of primary and secondary aberrations in multiple myeloma

• Sina Wenger,
• Milena Pantic,
• Gabriele Ihorst,
• Stepan Cysar,
• Marc-Antoine Calba,
• Christine Greil,
• Ralph Wäsch,
• Monika Engelhardt

Affiliations

Sina Wenger

Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg

Milena Pantic

Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg

Gabriele Ihorst

Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg, Germany; Clinical Trials Unit, Faculty of Medicine, University of Freiburg, Freiburg

Stepan Cysar

Department of Pathology, Faculty of Medicine, University of Freiburg, Freiburg

Marc-Antoine Calba

Department of Pathology, Faculty of Medicine, University of Freiburg, Freiburg

Christine Greil

Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg

Ralph Wäsch

Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg

Monika Engelhardt

Department of Medicine I Hematology and Oncology, Faculty of Medicine and Medical Center, University of Freiburg (UKF), Freiburg, Germany; Tumor Center Freiburg, Comprehensive Cancer Center Freiburg (CCCF), Freiburg